Ala-Val-Phe and Val-Phe: ACE inhibitory peptides derived from insect protein with antihypertensive activity in spontaneously hypertensive rats

Peptides

Volumn 31, Issue 3, 2010, Pages 482-488

  Vercruysse, Lieselot ^a   Van Camp, John ^a   Morel, Nicole ^b   Rougé, Pierre ^c   Herregods, Griet ^a   Smagghe, Guy ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

Bioactive peptides; Bioavailability stability; In vitro; In vivo; Organ baths rat aorta

Indexed keywords

ALANYLVALYLPHENYLALANINE; CHYMOTRYPSIN A; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSECT PROTEIN; LISINOPRIL; PEPSIN A; PEPTIDASE; TRIPEPTIDE; TRYPSIN; UNCLASSIFIED DRUG; VALYLPHENYLALANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARMYWORM; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG PURIFICATION; DRUG STABILITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HYDROLYSIS; HYDROPHOBICITY; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

HEXAPODA; LEPIDOPTERA; RATTUS; SPODOPTERA LITTORALIS;

EID: 77049092563     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.05.029     Document Type: Article

References (35)

1. Aito-Inoue M., Lackeyram D., Fan M.Z., Sato K., Mine Y. Transport of a tripeptide, Gly-Pro-Hyp, across the porcine intestinal brush-border membrane. J Peptide Sci 2007, 13:468-474.
2. Chang B.W., Chen R.L.C., Huang I.J., Chang H.C. Assays for angiotensin converting enzyme inhibitory activity. Anal Biochem 2001, 291:84-88.
3. Corradi H.R., Chitapi I., Sewell B.T., Georgiadis D., Dive V., Sturrock E.D., et al. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380. Biochemistry 2007, 46:5473-5478.
4. Corradi H.R., Schwager S.L.U., Nchinda A.T., Sturrock E.D., Acharya K.R. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J Mol Biol 2006, 357:964-974.
5. Costa E.L., Almeida A.R., Netto F.M., Gontijo J.A.R. Effect of intraperitoneally administered hydrolyzed whey protein on blood pressure and renal sodium handling in awake spontaneously hypertensive rats. Braz J Med Biol Res 2005, 38:1817-1824.
6. FitzGerald R.J., Murray B.A., Walsh D.J. Hypotensive peptides from milk proteins. J Nutr 2004, 134:980S-988S.
7. Fujita H., Yokoyama K., Yoshikawa M. Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 2000, 65:564-569.
8. Fujita H., Yoshikawa M. LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 1999, 44:123-127.
9. Hartmann R., Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 2007, 18:163-169.
10. Hayes M., Stanton C., Slattery H., O'Sullivan O., Hill C., Fitzgerald G.F., et al. Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. Appl Environ Microbiol 2007, 73:4658-4667.
11. Houston M.C. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Progress Cardiovasc Dis 2005, 47:396-449.
12. Ichimura T., Hu J.N., Aita D.Q., Maruyama S. Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce. J Biosci Bioeng 2003, 96:496-499.
13. Katayama K., Tomatsu M., Fuchu H., Sugiyama M., Kawahara S., Yamauchi K., et al. Purification and characterization of an angiotensin I-converting enzyme inhibitory peptide derived from porcine troponin C. Anim Sci J 2003, 74:53-58.
14. Korhonen H., Pihlanto A. Bioactive peptides: production and functionality. Int Dairy J 2006, 16:945-960.
15. Kouno K., Hirano S., Kuboki H., Kasai M., Hatae K. Effects of dried bonito (Katsuobushi) and captopril, an angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action. Biosci Biotechnol Biochem 2005, 69:911-915.
16. Lee R.P., Wang D., Lin N.T., Chou Y.W., Chen H.I. A modified technique for tail cuff pressure measurement in unrestrained conscious rats. J Biomed Sci 2002, 9:424-427.
17. Lopez-Fandino R., Otte J., Van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J 2006, 16:1277-1293.
18. Maeno M., Yamamoto N., Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1996, 79:1316-1321.
19. Miguel M., Manso M., Aleixandre A., Alonso M.J., Salaices M., Lopez-Fandino R. Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and anti hypertensive properties of peptides derived from egg white. J Agric Food Chem 2007, 55:10615-10621.
20. Miguel M., Manso M.A., Lopez-Fandino R., Alonso M.J., Salaices M. Vascular effects and antihypertensive properties of kappa-casein macropeptide. Int Dairy J 2007, 17:1473-1477.
21. Nakashima Y., Arihara K., Sasaki A., Mio H., Ishikawa S., Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002, 67:434-437.
22. Natesh R., Schwager S.L.U., Evans H.R., Sturrock E.D., Acharya K.R. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 2004, 43:8718-8724.
23. Natesh R., Schwager S.L.U., Sturrock E.D., Acharya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421:551-554.
24. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612.
25. Pripp A.H., Isaksson T., Stepaniak L., Sorhaug T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. Eur Food Res Technol 2004, 219:579-583.
26. Suetsuna K., Maekawa K., Chen J.R. Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. J Nutr Biochem 2004, 15:267-272.
27. Towler P., Staker B., Prasad S.G., Menon S., Tang J., Parsons T., et al. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 2004, 279:17996-18007.
28. Vercruysse L., Morel N., Van Camp J., Szust J., Smagghe G. Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta. Peptides 2008, 29:261-267.
29. Vercruysse L., Smagghe G., Herregods G., Van Camp J. ACE inhibitory activity in enzymatic hydrolysates of insect protein. J Agric Food Chem 2005, 53:5207-5211.
30. Vercruysse L., Smagghe G., Matsui T., Van Camp J. Purification and identification of an angiotensin I converting enzyme (ACE) inhibitory peptide from the gastrointestinal hydrolysate of the cotton leafworm, Spodoptera littoralis. Process Biochem 2008, 43:900-904.
31. Vercruysse L., Smagghe G., van der Bent A., van Amerongen A., Ongenaert M., Van Camp J. Bioinformatics as a theoretical tool to find new and high-potential sources of ACE inhibitory peptides. Peptides 2009, 30:572-582.
32. Vermeirssen V., Van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 2004, 92:357-366.
33. Wu J.P., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. J Agric Food Chem 2006, 54:732-738.
34. Yamamoto N., Ejiri M., Mizuno S. Biogenic peptides and their potential use. Curr Pharm Design 2003, 9:1345-1355.
35. Yoshii H., Tachi N., Ohba R., Sakamura O., Takeyama H., Itani T. Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks. Comp Biochem Physiol C: Toxicol Pharmacol 2001, 128:27-33.